Clinical Trial

Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMF-650 in Otherwise Healthy Overweight or Obese Participants.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-10
Trial Details
NCT Number NCT07223216
Lead Sponsor Biomea Fusion Inc.
Conditions Obesity
Enrollment 80 participants
Start Date 2025-10-23
Primary Completion 2026-05 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-09